Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
25 hedge funds and large institutions have $17.5M invested in Zosano Pharma Corporation in 2018 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 16 closing their positions.
350% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 2
22% less funds holding
Funds holding: 32 → 25 (-7)
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
38% less capital invested
Capital invested by funds: $28.5M → $17.5M (-$11M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.15M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$791K |
| 3 |
Morgan Stanley
New York
|
+$598K |
| 4 |
TI
Telemetry Investments
New York
|
+$405K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$328K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$2.27M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.89M |
| 3 |
HRCM
Hawk Ridge Capital Management
Los Angeles,
California
|
-$1.01M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.01M |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$504K |
ZSAN Hedge Fund Activity: Q2 2018 in Review
25 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q2 2018, worth a combined $17.5M — down 38% from $28.5M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of ZSAN and 10 opened new positions — a net loss of 6 holders — while 2 trimmed existing stakes and 9 added.
The largest buyer was Sabby Management, adding an estimated $1.15M. The largest seller was Monashee Investment Management, exiting entirely with an estimated $2.27M sold.
- 25 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q2 2018, down from 32 in Q1 2018.
- Funds reported $17.5M of Zosano Pharma Corporation stock for Q2 2018, down 38% quarter-over-quarter.
- 10 funds opened new Zosano Pharma Corporation positions in Q2 2018 and 16 closed out, a net change of -6 holders.
- The largest Zosano Pharma Corporation buyer in Q2 2018 was Sabby Management, an estimated $1.15M added.
- The largest Zosano Pharma Corporation seller in Q2 2018 was Monashee Investment Management, an estimated $2.27M sold.
Based on aggregated 13F filings for Q2 2018.